José Luis Cabero
Passion and experience to impulse entrepreneurship in life sciences | I enjoy growing with developing people | I get energy from unleashing innovation.
@fundaciorecerca.bsky.social
La Fundació Catalana per a la Recerca i la Innovació (FCRI) promou el talent científic des de l’escola, divulga la ciència i connecta la recerca amb les empreses.
@linagalvez.eu
Chair @EP_GenderEqual 🇪🇺Parliament S&D🌹@PSOE @FEPS_Europe Vice-Chair Ph.D. @EUI_EU 👨🎓 Economic History Prof. @pablodeolavide #Feminism 💜 & Social Justice
@broadinstitute.org
A multidisciplinary community of researchers with the mission to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. Broadinstitute.org
@michaelemann.bsky.social
Scientist/Author/Speaker; Presidential Distinguished Prof/Director Center for Science, Sustainability & the Media/Vice Provost for Climate, U. Penn; National Academy of Sciences; Royal Society; Tyler Prize
@peterhotezmdphd.bsky.social
Texas Medical Center (TMC) Pediatrics Professor-Vaccine Scientist-Author; Member, Philosophical Society of Texas "the oldest learned society in Texas established in 1837," TAMEST, National Academy of Medicine, American Academy of Arts and Sciences
@ysioscapital.bsky.social
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide. Sign up & stay tuned http://eepurl.com/duXVDv 📩
@raffcolo.bsky.social
ADCs, targeted therapies, chemistry, biotech, pharma. Associate Director @ Zymeworks
@jmaraganore.bsky.social
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer. CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
@ec.europa.eu
News and information from the European Commission. Social media and data protection policy: http://europa.eu/!MnfFmT
@erc.europa.eu
European Research Council, set up by the EU, funds top researchers of any nationality, helping them pursue great ideas at the frontiers of knowledge. #HorizonEU
@biocat.cat
Biocat drives the growth of the life sciences and health innovation ecosystem in Catalonia 🚀 biocat.cat
@ravindranize.bsky.social
Health reporter. Now: Covering longevity, aging and brain health at The New York Times. Then: Health tech for STAT, Politico and Business Insider. Reach me: [email protected].
@mmolteni.bsky.social
Writing about CRISPR, synthetic bio, reprotech and neuroscience for @statnews. Ex-WIRED. Berkeley journalism alum. Signal: mmolteni.13 ✉️ [email protected] https://www.statnews.com/
@tinkerr.bsky.social
Freelance health and science journalist. Clips from Medscape, Health Leaders, Nature, Boston Globe, Washington Post, Fast Company, Parents, News & Observer and more.
@irsicaixa.es
Líder en recerca sobre infeccions i immunitat | Leading research centre in infection and immunity.
@fundaciolluita.bsky.social
Referents en recerca clínica sobre malalties infeccioses. 🦠 #lluita #recerca #tractament #cura
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@robcaliff.bsky.social
@vishalgulati.bsky.social
Specialist computational biology and cognitive automation VC. Not a fan of mouse click economy. Founded @RecodeVentures #medsky #biosky #healthsky
@ecdc.europa.eu
We’re the European Centre for Disease Prevention and Control. We aim to strengthen EU’s defences vs infectious diseases. Here to promote public health.
@ema.europa.eu
EU regulatory authority working for public and animal health. We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam. https://www.ema.europa.eu/
@nature.com
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
@virusesimmunity.bsky.social
We study antiviral immunity and viral disease pathogenesis. We are developing mucosal vaccine strategies to prevent infection and transmission. #COVID19 #longCOVID #vaccines
@drkavitapatel.bsky.social
Stanford University Faculty, Venture Partner New Enterprise Associates NBC Medical Contributor and Obama Policy Alum
@elcollazo.bsky.social
Científico, profesor, escritor y divulgador. Web: https://elcollazo.com/. Columnas y Críticas de Danza: https://www.elespanol.com/autor/eduardo-lopez-collazo/
@lluismontoliu.bsky.social
Biotechnologist, interested in mammalian genomes and generation & use of genetically modified animals as models of human rare diseases, such as #albinism #CRISPR https://t.co/jI5suWIlYZ
@ageinves.bsky.social
Agencia Estatal de Investigación de España. Fomentamos la investigación científica y técnica mediante la asignación de los recursos públicos.
@science.org
The world's leading outlet for cutting-edge research in all areas of science. https://www.science.org
@leileiwu.bsky.social
reporting on drugs and biotechs @endpoints • email me: [email protected] • Signal: leileiwu.24 • ✌️
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@thepou1.bsky.social
Danish biotech start-up builder living in Paris | RNA Tx & immunotherapy aficionado | Family barista | Kongeblå & Gooner
@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@afigueroainibic.bsky.social
R4 Research Group Leader | Epithelial Plasticity & Metastasis Group at INIBIC
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@rubensebas.bsky.social
Biotech VC investor | Board member | Talking about science, therapeutics, drug development, startups and pharma | PhD @crg.eu https://www.linkedin.com/in/rubensebastianperez/
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@jordixiol.bsky.social
Science, history, and drug development | https://vineyardbooks.substack.com/
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺